ArticleOncotarget2017

TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.